Dan Skovronsky, Eli Lilly chief scientific and medical officer (Eli Lilly via YouTube)
Q&A: Lilly science chief Dan Skovronsky talks dealmaking, AI and consistent investing
Eli Lilly is on a hot streak. It’s about to find out whether its diabetes drug can also be marketed for weight management. Its Alzheimer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
